MEDAPP S.A. ZY -10 (WQ1) - Total Liabilities
Based on the latest financial reports, MEDAPP S.A. ZY -10 (WQ1) has total liabilities worth €13.06 Million EUR (≈ $15.27 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See WQ1 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
MEDAPP S.A. ZY -10 - Total Liabilities Trend (2021–2025)
This chart illustrates how MEDAPP S.A. ZY -10's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of MEDAPP S.A. ZY -10.
MEDAPP S.A. ZY -10 Competitors by Total Liabilities
The table below lists competitors of MEDAPP S.A. ZY -10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CGN Resources Ltd
AU:CGR
|
Australia | AU$70.82K |
|
Woodlandor Holdings Bhd
KLSE:7025
|
Malaysia | RM6.95 Million |
|
TGS Esports Inc
V:TGS
|
Canada | CA$3.69 Million |
|
ENEFI Energiahatekonysagi Nyrt
BUD:ENEFI
|
Hungary | Ft649.11 Million |
|
Intelligent Living Application Group Inc
NASDAQ:ILAG
|
USA | $3.63 Million |
|
Riedel Resources Ltd
AU:RIE
|
Australia | AU$712.75K |
|
Duta Pertiwi Nusantara Tbk
JK:DPNS
|
Indonesia | Rp6.34 Billion |
|
Craneware Plc
LSE:CRW
|
UK | GBX213.50 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down MEDAPP S.A. ZY -10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of MEDAPP S.A. ZY -10 to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MEDAPP S.A. ZY -10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MEDAPP S.A. ZY -10 (2021–2025)
The table below shows the annual total liabilities of MEDAPP S.A. ZY -10 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €13.06 Million ≈ $15.27 Million |
+12.49% |
| 2024-12-31 | €11.61 Million ≈ $13.57 Million |
+29.10% |
| 2023-12-31 | €8.99 Million ≈ $10.51 Million |
+81.81% |
| 2022-12-31 | €4.95 Million ≈ $5.78 Million |
-31.61% |
| 2021-12-31 | €7.23 Million ≈ $8.46 Million |
-- |
About MEDAPP S.A. ZY -10
MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D… Read more